Physician profile
Thomas Patton
NPI 1205813854
$3,023.72
in general payments reported to CMS, 2019-2025
14 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.41 · 2020: $45.85 · 2021: $119 · 2022: $160 · 2023: $851 · 2024: $1,664 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,250 · Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,250.00 |
| Food and Beverage | $387.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,250.00 | 2023-2024 | Davinci Xi |
| Ucb, INC. | $420.92 | 2020-2025 | Briviact, Rystiggo |
| Scilex Pharmaceuticals INC. | $92.82 | 2021-2024 | Ztlido |
| Lundbeck LLC | $38.72 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $28.65 | 2019 | |
| Smith+Nephew, INC. | $26.70 | 2022 | |
| Alexion Pharmaceuticals, INC. | $25.92 | 2025 | Ultomiris |
| Livanova USA, INC. | $25.71 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Abbvie INC. | $25.60 | 2021 | |
| Organon LLC | $25.16 | 2022 | |
| Catalyst Pharmaceuticals, INC. | $22.91 | 2025 | |
| Myovant Sciences INC. | $17.39 | 2022 | |
| Pernix Therapeutics Holdings, INC. | $12.22 | 2019 | |
| Allergan, INC. | $11.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Patton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.